Follow the Wockhardt Limited stock price and the full management transaction log of the company, a listed equity based in India. Shares trade on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Wockhardt Limited has published 34 insider filings. Market capitalisation: €309.4bn. The latest transaction was filed on 27 December 2024 (Purchase). Among the most active insiders: Themisto Trustee Company Private Limited. All data is accessible without an account.
34
Insider Decl.
n/a
Thresholds
€50,321
2 ops.
Buy Volume
€26m
13 ops.
Sell Volume
10Σ signal
Buys €50,321€26m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,017 of 29,020 companies
39.2
score / 100
Value
26
Quality
52
FCF yld0.1%
Earn yld0.7%
EV/EBITDA49.3x
ROE4.0%
Gross mgn63%
Net mgn6.4%
Debt/EBITDA3.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
500,000 shares@ ₹553.000.0016% mcap84.2% of flowEquity SharesSEBI:0e7ff7a3a234f7cb617d3a48ceac5997b1e0efb2
25 of 34 declarations
About Wockhardt Limited
Wockhardt Limited is an Indian pharmaceutical company that specializes in the research, development, and manufacturing of medications. It primarily operates in the pharmaceutical and biopharmaceutical markets.